MAY 08, 2020 7:31 AM PDT

Cholesterol Drugs May Boost Healthy Gut Bacteria in Obese People

WRITTEN BY: Annie Lennon

While statins have long been known for their efficacy in treating high cholesterol, until recently, there was no evidence on its benefits for the microbiome. Now though, tesearchers have found that obese people who take cholesterol-lowering statin drugs may be more likely to have healthier gut bacteria than those who don’t.

For their study, researchers from the Flanders Institute for Biotechnology in Belgium used data from the European Union study called MetaCardis to explore the link between cardiovascular disease and gut bacteria. The research project is known for having microbiome data from over 2,000 individuals from Europe across 1,400 variables including medication and body-mass index. 

From the 888 samples studied, they found that those with higher levels of Bacteroides 2 (Bact2) enterotype (a certain microbiome configuration) tended to have a higher body-mass index and a higher liklihood of being obese. This is particularly noteworthy as the Bact2 enterotype is associated with inflammation. Previous studies have shown that while 75% of people with inflammatory bowel disease have the enterotype, just 15% of those without it have the condition. 

The researchers also found that the pattern of enterotypes in obese people taking statins significnatly differed from those who do not take the drug. While just 5.9% of those taking statins had the Bact2 entereotype, 17.7% of those not taking the drug had the Pact 2 microbiome configuration. These results were repeated when analyzing data from the Flemish Gut Flora Project. 

The authors of the study caution that although their findings open an interesting avenue for further research, they should not be taken conclusively. When calculating their results, lifestyle and socioeconomic factors for example were not taken into account. More than this, due to the lack of ethnic diversity in their samples, these results may not apply for different ethnic groups. 

 

Sources: Forbes, Nature

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
MAY 07, 2020
Cancer
MAY 07, 2020
Yet Another Cancer Linked Tyrosine Kinase
In a cell, there are tens of thousands of individual components. Each component has a specific activity or role that the ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
Fecal Transplant Helps Fight off Antibiotic Resistance
Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has ...
MAY 16, 2020
Neuroscience
MAY 16, 2020
Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection
Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that av ...
MAY 25, 2020
Genetics & Genomics
MAY 25, 2020
FDA Approves the First Treatment for Neurofibromatosis 1
In a major breakthrough, the Food and Drug Administration has approved a treatment for a genetic disorder called neurofi ...
MAY 25, 2020
Drug Discovery & Development
MAY 25, 2020
Hydrochloroquine Increases Risk of Death by COVID-19
Researchers have found that hydroxychloroquine is not an effective treatment for COVID-19. Their study found that it lea ...
Loading Comments...